Elsevier

The Lancet

Volume 337, Issue 8749, 4 May 1991, Pages 1052-1054
The Lancet

ORIGINAL ARTICLES
Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus

https://doi.org/10.1016/0140-6736(91)91705-YGet rights and content

Abstract

von Hippel-Lindau syndrome (HLS), an autosomal-dominant inherited disease, was studied in 92 affected subjects from 29 kindreds. In an initial survey to identify HLS gene carriers, all patients treated at the University of Freiburg for angiomatosis retinae (22), haemangioblastoma of the central nervous system (CNS) (63), and phaeochromocytoma (54) were examined as potential HLS gene carriers. HLS was diagnosed in 86% of the patients with angiomatosis retinae, 19% of the patients with haemangioblastoma of the CNS, and 19% of the patients with phaeochromocytoma. Based on these and on an additional 49 newly diagnosed cases (24 by clinical examination and 25 by pedigree analysis), the calculated prevalence of the disease in the district of Freiburg, Germany, with a population of 1·909 million is 1/38 951. There was a striking tendency for familial clustering of HLS features in affected kindreds. Both angiomatosis retinae and haemangioblastoma of the CNS occurred in most families, whereas renal lesions and/or pancreatic cysts and phaeochromatocytoma were mutually exclusive. This finding suggests that HLS is caused by different mutations within a complex genetic locus, or additional genetic lesions, which cooperate with the HLS gene on chromosome 3p. The data point to a linear sequence of features as follows: phaeochromocytoma, angiomatosis retinae, haemangioblastoma of the CNS, renal lesions, pancreatic cysts, and epididymal cystadenoma.

References (25)

  • Br Seizinger et al.

    Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma

    Nature

    (1988)
  • Rb Welch

    Fluorescein angiography in sickle-cell retinopathy and von Hippel-Lindau disease

    Int Ophthalmol Clin

    (1977)
  • Cited by (284)

    • von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance

      2022, European Journal of Medical Genetics
      Citation Excerpt :

      Supplementary Table 1 gives the frequencies of vHL-associated manifestations, mean ages at manifestation onset, and the frequencies of vHL among patients with the various manifestation types, based on a systematic review of published vHL cohort studies. The prevalence of vHL has been found to be 1:46,900 in Denmark and has internationally been reported to be 1: 36,000–91,000 (Binderup et al., 2016; Evans et al., 2010; Maddock et al., 1996; Maher et al., 1991; Neumann and Wiestler, 1991). No founder effects were identified in the Danish vHL cohort (Binderup et al., 2016).

    • Management of the patient with incidental bilateral adrenal nodules

      2021, Journal of Clinical and Translational Endocrinology: Case Reports
    View all citing articles on Scopus
    View full text